Ignite Creation Date:
2025-12-24 @ 7:15 PM
Ignite Modification Date:
2025-12-25 @ 4:52 PM
Study NCT ID:
NCT00268203
Status:
COMPLETED
Last Update Posted:
2017-01-09
First Post:
2005-12-20
Is NOT Gene Therapy:
False
Has Adverse Events:
True
Brief Title:
Expanded Access Study Of BEXXAR® For Low Grade And Transformed Low-Grade Non-Hodgkin's Lymphoma
Sponsor:
GlaxoSmithKline
Organization:
Key Dates - Follows AllAPIJSON File Order
Start Date:
1998-09
Start Date Type:
None
Primary Completion Date:
2000-03
Primary Completion Date Type:
ACTUAL
Completion Date:
2013-02
Completion Date Type:
ACTUAL
First Submit Date:
2005-12-20
First Submit QC Date:
None
Study First Post Date:
2005-12-22
Study First Post Date Type:
ESTIMATED
Results First Submit Date:
2013-10-10
Results First Submit QC Date:
None
Results First Post Date:
2013-12-09
Results First Post Date Type:
ESTIMATED
Results First Post QC Date:
None
Results First Post QC Date Type:
None
Disp First Submit Date:
None
Disp First Submit QC Date:
None
Disp First Post Date:
None
Disp First Post Date Type:
None
Last Update Submit Date:
2016-11-18
Last Update Post Date:
2017-01-09
Last Update Post Date Type:
ESTIMATED